Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 9/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 4/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16922539 | 0.99 | LIMK1 (0.41) | LIMK1CDK5CDK5R1ALOX5LIMK2 | |
| SCHEMBL16922473 | 0.95 | LIMK1 (0.43) | LIMK1CDK5CDK5R1ALOX5LIMK2 | |
| SCHEMBL21263398 | 0.90 | LIMK1 (0.39) | LIMK1CDK5CDK5R1ALOX5EGFR | |
| SCHEMBL21032093 | 0.90 | LIMK1 (0.42) | LIMK1CDK5CDK5R1ALOX5EGFR | |
| SCHEMBL19937172 | 0.89 | CYP11B1 (0.36) | LIMK1CDK5CDK5R1ALOX5LIMK2 | |
| SCHEMBL22763458 | 0.88 | LIMK1 (0.41) | LIMK1CDK5CDK5R1ALOX5EGFR | |
| SCHEMBL19936966 | 0.88 | KDM4E (0.40) | LIMK1CDK5CDK5R1ALOX5LIMK2 | |
| SCHEMBL16922488 | 0.88 | TNF (0.37) | LIMK1LIMK2PIK3CA | |
| SCHEMBL21263342 | 0.88 | LIMK1 (0.38) | LIMK1CDK5CDK5R1ALOX5LIMK2 | |
| SCHEMBL21263478 | 0.88 | LIMK1 (0.38) | LIMK1CDK5CDK5R1ALOX5EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9755159-B2 | Organic materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | OCIAD1, OCIAD2, SLC25A21 | LIMK1 4180/4885CDK5 1881/4885CDK5R1 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.